ERBB2 and breast cancer: Although some pathological factors, including estrogen receptor (ER), progesterone receptor (PR) and c-erbB-2 (HER2), have been widely used as a reference in clinical diagnosis and treatment, their prognostic value for breast cancer still has certain limitations.